Allergan, Inc. (NYSE:AGN)

Investors Torch Mallinckrodt on Report of Possible Bankruptcy Filing

Mallinckrodt PLC (NYSE: MNK), a maker of specialty and generic drugs, reportedly has hired advisors to help the company decided whether to file for bankruptcy protection ahead of a federal ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Apple, Chipotle, Costco, Exxon, Netflix, Qualcomm, Ulta, US Bancorp and More

Stocks were indicated to open marginally lower on Thursday, but the three major equity indexes remain effectively just under their all-time highs. The bull market is now well over 10 ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack, Wingstop and More

Stocks were indicated to open marginally higher on Tuesday as the earnings floodgates have begun to open. The bull market is now well over 10 years old, and 2019 has ...
Read Full Story »

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan PLC (NYSE: AGN) shares jumped on Tuesday after the company announced that it would be acquired by AbbVie Inc. (NYSE: ABBV) in a cash and stock transaction. The transaction ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

Stocks were indicated to open higher yet again on Tuesday, as June has turned into a complete role reversal from May's "sell in May" theme that was winning. Investors need ...
Read Full Story »

Top Analyst Upgrades and Downgrades: 3D Systems, Allergan, Alcon, Booking, GoPro, IAC/Interactive, Lowe’s, Yelp and More

The futures were trading lower this morning as nervous investors across Wall Street await details on the success or lack thereof in regards to the trade negotiations going on between ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Stocks were indicated to open marginally higher on Wednesday ahead of the FOMC decision on interest rates. With the market having recouped so much ground in 2019, investors need to ...
Read Full Story »

Merrill Lynch Adds Top Large Cap Pharmaceutical Leader to US 1 List

With earnings reporting for the fourth quarter more than half over, and the first quarter of 2019 about the same, many of the top companies we follow on Wall Street ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Shell, ServiceNow, Tiffany and More

Stocks surged higher on Wednesday after strong post-earnings reactions from Apple and Boeing, and then Federal Reserve Chair Jerome Powell helped the markets by indicating that the Fed would be ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More

Stocks were indicated to open higher on Wednesday with positive earnings reactions from Apple and Boeing. Earnings season has been off to a mixed start at the start of 2019, ...
Read Full Story »

Tuesday’s Biggest Winners and Losers in the S&P 500

January 29, 2019: The S&P 500 closed down 0.2% at 2,640.01. The DJIA closed up 0.2% at 24,580.50. Separately, the Nasdaq closed down 0.8% at 7,028.29. Tuesday was a down ...
Read Full Story »

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

With just over six weeks left in what has been a very volatile 2018, many investors are wondering which direction the market will take now that Democrats are taking over ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Stocks were indicated to open lower on Thursday morning, though the S&P 500 hit an all-time high earlier in the week. Earnings season is all but over now and was ...
Read Full Story »

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch. This should not be ...
Read Full Story »

Tesla, Schlumberger and 4 Others With Recent Golden Crosses or Death Crosses

Golden crosses and death crosses are common signals in technical analysis and refer to the relationship between short-term and long-term moving averages. The golden cross typically is seen as a ...
Read Full Story »